monoclonal antibodies (Zalgen/Tulane/UTMB)

N/A

Report date: 2025/03/20 15:30:00

Base Information

Drug Namemonoclonal antibodies (Zalgen/Tulane/UTMB)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZalgen Labs LLC
China Registration ClassN/A

Develop Information

Active CompaniesZalgen Labs LLCUniversity Of Texas Medical BranchTulane University
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A